top of page
Argent's CannEpil™ Wins Approval for German Prescription Under Special Access Scheme
Argent BioPharma (ASX: RGT) has secured approval for its cannabinoid-based epilepsy treatment, CannEpil™, to be prescribed in Germany....
Apr 3
bottom of page